James Rake - Concepedia

Author

James Rake

Wayne State University

Also Known As

J B Rake, J Rake, J. B. RAKE, J. B. Rake, J. Rake, J.B. Rake, JAMES B. RAKE, James B. Rake, James Rake

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Wayne State University Sanofi (United States)Carestream (United States)Sterling Research Group (United States)Harper University Hospital

About

James Rake is an author at Wayne State University specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	645
2	Biochemistry	5	5	232
3	Health Sciences	3	3	170
4	Natural Sciences	3	3	81
5	Engineering	2	2	55

James Rake

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Formulation and Antitumor Activity Evaluation of Nanocrystalline Suspensions of Poorly Soluble Anticancer Drugs Elaine Merisko‐Liversidge, Pramod P. Sarpotdar, Joseph G. Bruno, Pharmaceutical Research	1996	231
Bacterial inhibitory effects of nitrite: inhibition of active transport, but not of group translocation, and of intracellular enzymes John M. Yarbrough, James Rake, R. G. Eagon Applied and Environmental Microbiology BacteriologyEscherichia ColiMicrobial PhysiologyDrug ResistanceReactive Nitrogen Specie	1980	117
Nitrite inhibition of aerobic bacteria John J. Rowe, John M. Yarbrough, James Rake, Current Microbiology Reactive Nitrogen SpecieMicrobial EcologyEnvironmental MicrobiologyMicrobiologyMedicine	1979	98
Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxylic acid and related derivatives Mark P. Wentland, George Y. Lesher, Michael Reuman, Journal of Medicinal Chemistry	1993	73
Glycopeptide antibiotics: A mechanism-based screen employing a bacterial cell wall receptor mimetic. James Rake, Robert A. Gerber, R. J. MEHTA, The Journal of Antibiotics	1986	47
Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human origin Thomas H. Corbett, Chiab Panchapor, Lisa Polin, Investigational New Drugs Tumor BiologyThioxanthone Sr271425MedicinePharmacologyHuman Origin	1999	36
Inhibition of platelet-derived growth factor-mediated signal transduction by transforming ras. Suppression of receptor autophosphorylation. James Rake, Miguel A. Quiñones, Douglas V. Faller Journal of Biological Chemistry Human GrowthImmunologyCell ProliferationCell GrowthThrombosis	1991	35
The antitumor activity of novel pyrazoloquinoline derivatives Mark P. Wentland, Suzanne C. Aldous, M. D. GRUETT, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesPharmacological Agent	1995	35
Tumor Models and the Discovery and Secondary Evaluation of Solid Tumor Active Agents Thomas H. Corbett, Fred Valeriote, Patricia LoRusso, International Journal of Pharmacognosy Tumor BiologyTumor HeterogeneityTheranosticsTumor ModelsAnti-cancer Agent	1995	35
Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyridol [1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161) Susan Coughlin, Deborah W. Danz, R. Robinson, Biochemical Pharmacology Medicinal ChemistryAntitumor ActivityBiochemistryMedicineNatural Sciences	1995	34

Page 1